v3 Template
T

Teva Pharmaceuticals

Biopharmaceuticals Parsippany, N.J. and Tel Aviv, Israel ~1K employees
Founded
--
Employees (Est.)
~1K
52 leaders known
Total Funding
$4.7B
Funding Rounds
3
Last Funding
2026-03-03

About Teva Pharmaceuticals

Teva Pharmaceuticals is a leading innovative biopharmaceutical company focused on improving health globally through science and drug development. Enabled by a world-class generics business, Teva strives to deliver quality medicines with integrity and ethical practices, aiming to treat and support patients while innovating at every stage of drug development and delivery.

Products & Services

Generic Medicines:High-quality, affordable alternatives to brand-name drugs.
Biosimilars:Biologic medicines similar to existing reference products, offering cost-effective treatment options.
Innovative Medicines:New therapeutic solutions developed for various conditions through advanced R&D.
Consumer Healthcare:Over-the-counter products for general health and wellness.
Out-Licensing Generic Pharmaceuticals:Licensing of generic drugs through partnerships.

Specialties

Neurological Conditions Immuno-Oncology Movement Disorders Schizophrenia Migraine Treatment Clinical Trials Generics and Biosimilars Innovative Therapeutic Areas

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Strategic Growth Capital
T: -
FT: Strategic Growth Capital
A: 400000000
MR: -
FA: 400 million
FAN: 400000000
D: 2026-03-03
FD: 2026-03-03
1 investors
2 RT: Debt
T: -
FT: Debt
A: 2300000000
MR: -
FA: 2,300,000,000
FAN: 2300000000
D: 2025-05-20
FD: 2025-05-20
-
3 RT: Debt
T: -
FT: Debt
A: 2000000000
MR: -
FA: $2,000,000,000 equivalent
FAN: 2000000000
D: 2025-05-19
FD: 2025-05-19
-
Strategic Growth Capital Latest
2026-03-03
$400.0M
1 investor (Pro only)
Debt 2025-05-20
$2.3B
Debt 2025-05-19
$2.0B

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

C

Chris Fox

EVP, US Commercial

S

Sharon Biran

Administrative Professional

A

Amy Melchior

Medical Writer

T

Teresa Domagala

Scientific Operations Lead

V

Virginie Peirs

Senior Director, Regulatory Affairs

S

Subhajit Goswami

Sr. Director, Manufacturing

View 49 more team members with Pro

Unlock Full Team Directory

Recent News

Teva Pharmaceuticals Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceuticals
Company Size
~1K employees (est.)
Locations
Parsippany, N.J. and Tel Aviv, Israel
TEL AVIV, Israel
Tel Aviv, Israel +4 more

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro